Combined Therapy for Distant Metastasis of Sacral Chordoma

dc.contributor.authorÖzkal, B
dc.contributor.authorYaldiz, C
dc.contributor.authorTemiz, P
dc.contributor.authorTemiz, C
dc.date.accessioned2025-04-10T10:34:18Z
dc.date.available2025-04-10T10:34:18Z
dc.description.abstractChordomas are known as rare primary malign tumours that have formed from primitive notochord remains. Sacral chordomas grow slowly but locally and aggressively. Chordomas are locally invasive and have low tendency to metastasis and have a poor prognosis in long-term follow-up. Metastasis may be seen in a rate of 5-40% of the chordomas. Metastasis of chordomas is common in liver, lung, lymph nodes, peritoneum, and brain. The treatment approaches, including surgery, have been discussed in the literature before. Susceptibility to radiotherapy and chemotherapy is controversial in these tumours. The success of surgical treatment affects survival directly. In this report, we will report a sacral chordoma case in which an intraperitoneal distant metastasis occurred and discuss the surgical approach.
dc.identifier.e-issn2090-6919
dc.identifier.issn2090-6900
dc.identifier.urihttp://hdl.handle.net/20.500.14701/40465
dc.language.isoEnglish
dc.titleCombined Therapy for Distant Metastasis of Sacral Chordoma
dc.typeArticle

Files